Sign In
Buy ATNM
$1.16
-0.0600 (-4.92%)
At Close: Jun 03, 2026
NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
NEW YORK CITY, NY / ACCESS Newswire / April 17, 2025 / WHY: New York, N.Y., April 17, 2025.
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for Investors - Contact Levi & Korsinsky
04:45pm, Thursday, 17'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
Levi & Korsinsky Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025 - ATNM
12:15pm, Thursday, 17'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
NEW YORK, NY / ACCESS Newswire / April 17, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
NEW YORK CITY, NY / ACCESS Newswire / April 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Actin
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. Lawsuit - ATNM
05:45am, Thursday, 17'th Apr 2025
NEW YORK , April 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Actinium Pharmaceuticals, Inc. (NYSE: ATNM). Shareholders who purchased shares of ATNM duri
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
NEW YORK CITY, NY / ACCESS Newswire / April 16, 2025 / WHY: New York, N.Y., April 16, 2025.
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM). S
Levi & Korsinsky Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025 - ATNM
10:45am, Wednesday, 16'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
10:18am, Wednesday, 16'th Apr 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Actinium To Contact Him Directly To Discuss Their Options
Ibotta, Inc. Investors: Company Investigated by the Portnoy Law Firm
10:01am, Wednesday, 16'th Apr 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. Lawsuit - ATNM
07:25am, Wednesday, 16'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal se
